Aspoxicillin

This classification denotes a penicillin antibiotic with the molecular formula C21H27N5O7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0745KNO26J, chemically known as glycinamide, n-methyl-d-asparaginyl-n-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-d-2-(4-hydroxyphenyl)-, (2s-(2-alpha,5-alpha,6-beta))- but generally known as aspoxicillin, which bears US NIH Compound Identifier 71961. European Medicines Agency schedules Aspoxicillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05585MIG. The term ASPOXICILLIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). ASPOXICILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule aspoxicillin under HS 29411090 and SITC 54131. As of Q4 2014, ASPOXICILLIN remains the US FDA Preferred Term for this commodity. Aspoxicillin bears US NLM identifiers UMLS ID C0104449 and NCI Concept Code C72706. SMILES: S1C2N(C(C1(C)C)C(=O)O)C(=O)C2NC(=O)C(NC(=O)C(N)CC(=O)NC)C1CCC(O)CC1.